|
Session 37
Oral Abstracts
Pathogenesis of HIV Complications
Wednesday, 10 am-12:15 pm
Room: Room 517b-d |
| 10:00 am 145 |
Association between Modifiable and Non-modifiable Risk Factors and Specific Causes of Death in the HAART Era: The Data Collection on Adverse Events of Anti-HIV Drugs Study
Colette Smith and D:A:D Study Group
Univ Coll London Med Sch, UK |
| 10:15 am 146 |
HIV Infection Is an Independent Risk Factor for Atherosclerosis Similar in Magnitude to Traditional Cardiovascular Disease Risk Factors
Carl Grunfeld*1,2, J Delaney3, C Wanke4, J Currier5, R Scherzer1,2, M Biggs3, S Sidney6, J Polak7, D O'Leary7, R Kronmal3, and FRAM Study
1Univ of California, San Francisco, US; 2VAMC, San Francisco, CA, US; 3Univ of Washington, Seattle, US; 4Tufts Univ Sch of Med, Boston, MA, US; 5Univ of California, Los Angeles, US; 6Kaiser Permanente, Oakland, CA, US; and 7Tufts Med Ctr, Boston, MA, US |
| 10:30 am 147 |
Nef-mediated Suppression of ABCA1-dependent Cholesterol Efflux Activity May Contribute to Primary Dyslipidemia in SIV-infected Macaques
Michael Bukrinsky*1, B Asztalos2, Z Mujawar3, M Morrow4, M Fitzgerald3, C Wanke2, R Shannon4, M Geyer5, F Kirchhoff6, and K Mansfield7
1George Washington Univ, Washington, DC, US; 2Tufts Univ, Boston, MA, US; 3Massachusetts Gen Hosp, Boston, US; 4Univ of Pennsylvania Sch of Med, Philadelphia, US; 5Max-Planck-Inst for Molecular Physiology, Dortmund, Germany; 6Inst of Virology, Univ of Ulm, Germany; and 7New England Primate Res Ctr, Southborough, MA, US |
| 10:45 am 148 |
Positive Paths: A Motivational Intervention for Smoking Cessation among HIV+ Smokers
Karen Tashima*1,2, R Niaura1, E Richardson3, C Stanton1, M De Dios1, and M Kojic1,2
1Warren Alpert Med Sch, Brown Univ, Providence, RI, US; 2Miriam Hosp, Providence, RI, US; and 3Univ of Massachusetts, Dartmouth, US |
| 11:00 am 149 |
High-density Lipoprotein Particles but Not Low-density Lipoprotein Particles Predict Cardiovascular Disease Events in HIV Patients: Strategies for Management of ART Study
Daniel Duprez and INSIGHT/SMART Group
Univ of Minnesota, Minneapolis, US |
| 11:15 am 150LB |
Inflammatory Markers among Abacavir and non-Abacavir Recipients in the Womens’ Interagency HIV Study and the Multicenter AIDS Cohort Study
Frank Palella*1, S Gange2, R Elion3, L Benning2, R Kaplan4, C WIllliams5, A Landay6, L Jacobson2, and R Tracy7
1Feinberg Sch of Med, Northwestern Univ, Chicago, IL, US; 2Johns Hopkins Univ, Baltimore, MD, US; 3Whitman Walker Clinic, Washington, DC, US; 4Albert Einstein Coll of Med, New York, NY, US; 5NIAID, NIH, Bethesda, MD, US; 6Rush Univ, Chicago, IL, US; and 7Univ of Vermont, Burlington, US |
| 11:30 am 151LB |
Platelet Hyper-Reactivity in HIV-1-infected Patients on Abacavir-containing ART
Claudette Satchell*1, E O'Connor2, A Peace3, A Cotter2, G Sheehan2, T Tedesco3, P Doran2, W Powderly1, D Kenny3, and P Mallon1,2
1Univ Coll Dublin, Ireland; 2Mater Misercordiae Univ Hosp, Dublin, Ireland; and 3Royal Coll of Surgeons in Ireland, Dublin |
| 11:45 am 152 |
Abacavir and Cardiovascular Risk
Peter Reiss
Academic Med Ctr, Univ of Amsterdam, The Netherlands |
|
